Inadequate antimicrobial prophylaxis during surgery: a study of beta-lactam levels during burn debridement

J Antimicrob Chemother. 2007 Jul;60(1):166-9. doi: 10.1093/jac/dkm128. Epub 2007 May 15.

Abstract

Objectives: To determine how long single-dose prophylactic antibiotic regimens for burns surgery maintained plasma concentrations above the MICs for target organisms during surgery.

Patients and methods: We monitored antibiotic plasma concentrations in 12 patients (mean +/- SD 43 +/- 12% total burn surface area) throughout debridement surgery after administration of the standard prophylactic antibiotic dosing regimens of either 1 g of intravenous cefalotin or 4.5 g of intravenous piperacillin/tazobactam.

Results: The eschar debridement and grafting procedures ranged in duration from 2.25 to over 8.5 h. The duration of total plasma cefalotin concentration above an MIC of 0.2 mg/L for Staphylococcus aureus was 6.49 +/- 2.85 h, whereas the mean duration of total plasma piperacillin concentration above an MIC of 64 mg/L for Pseudomonas aeruginosa was only 1.15 +/- 0.59 h. None of the patients dosed with piperacillin/tazobactam was adequately protected for the duration of their surgery and adequate prophylaxis was only evident in four of the nine patients administered cefalotin.

Conclusions: These results suggest a need to review antibiotic prophylaxis dosage regimens for burns surgery and the adoption of regimens that will minimize the risk of infection in this high-risk patient group. It is suggested that the antibiotic prophylaxis guideline for burn debridement surgery be modified to include re-dosing or a continuous infusion of beta-lactam antibiotics.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Anti-Bacterial Agents* / administration & dosage
  • Anti-Bacterial Agents* / pharmacokinetics
  • Anti-Bacterial Agents* / therapeutic use
  • Antibiotic Prophylaxis*
  • Bacterial Infections / microbiology
  • Bacterial Infections / prevention & control*
  • Burns / surgery*
  • Cephalothin / administration & dosage
  • Cephalothin / pharmacokinetics
  • Cephalothin / therapeutic use
  • Debridement / adverse effects*
  • Drug Administration Schedule
  • Drug Therapy, Combination
  • Humans
  • Penicillanic Acid / administration & dosage
  • Penicillanic Acid / analogs & derivatives
  • Penicillanic Acid / pharmacokinetics
  • Penicillanic Acid / therapeutic use
  • Piperacillin / administration & dosage
  • Piperacillin / pharmacokinetics
  • Piperacillin / therapeutic use
  • Pseudomonas aeruginosa / drug effects
  • Staphylococcus aureus / drug effects
  • Tazobactam
  • beta-Lactams* / administration & dosage
  • beta-Lactams* / pharmacokinetics
  • beta-Lactams* / therapeutic use

Substances

  • Anti-Bacterial Agents
  • beta-Lactams
  • Penicillanic Acid
  • Cephalothin
  • Tazobactam
  • Piperacillin